Rules-Based Medicine and Psynova Neurotech Announce Companion Diagnostic Collaboration with Roche

Applied Clinical Trials Online reported on December 3rd that Rules-Based Medicine, Inc. announced that Psynova Neurotech Limited, a majority-owned subsidiary of RBM, has executed an exclusive research and licensing agreement with Roche to collaborate on the discovery, development, validation and commercialization of diagnostic immunoassays to aid the clinical development and commercial differentiation of novel treatments for schizophrenia.

Learn more: Rules-Based Medicine and Psynova Neurotech Announce Companion Diagnostic Collaboration with Roche